| Names | |
|---|---|
| Preferred IUPAC name | 1-Bromo-3-chloro-5,5-dimethylimidazolidine-2,4-dione |
| Other names | 1-Bromo-3-chloro-5,5-dimethylhydantoin BCDMH Bromochloro-5,5-dimethylhydantoin Bromochlorodimethylhydantoin |
| Pronunciation | /ˌbroʊ.moʊˌklɔː.roʊ.haɪˈdæn.tɔɪn/ |
| Identifiers | |
| CAS Number | 32718-18-6 |
| Beilstein Reference | 80334 |
| ChEBI | CHEBI:81995 |
| ChEMBL | CHEMBL2106429 |
| ChemSpider | 14128 |
| DrugBank | DB11345 |
| ECHA InfoCard | 03e9aada-2cbe-4076-bf6e-3e9c1f8fa3ff |
| EC Number | 238-272-9 |
| Gmelin Reference | 146723 |
| KEGG | C06828 |
| MeSH | D015242 |
| PubChem CID | 12364 |
| RTECS number | BP9625000 |
| UNII | HX38450316 |
| UN number | UN3077 |
| CompTox Dashboard (EPA) | DTXSID5020216 |
| Properties | |
| Chemical formula | C5H6BrClN2O2 |
| Molar mass | 197.37 g/mol |
| Appearance | White or off-white crystalline powder |
| Odor | Faint halogen odor |
| Density | 1.72 g/cm³ |
| Solubility in water | 0.2 g/100 mL (25°C) |
| log P | 2.18 |
| Vapor pressure | 1.80E-6 mmHg at 25°C |
| Acidity (pKa) | 8.5 |
| Magnetic susceptibility (χ) | -72.0e-6 cm³/mol |
| Refractive index (nD) | 1.600 |
| Viscosity | Viscous liquid |
| Dipole moment | 2.56 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 309.5 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | –133 kJ mol⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -3932 kJ·mol⁻¹ |
| Pharmacology | |
| ATC code | D08AX05 |
| Hazards | |
| Main hazards | Harmful if swallowed, causes severe skin burns and eye damage, may cause respiratory irritation, very toxic to aquatic life. |
| GHS labelling | GHS02, GHS05, GHS07, GHS09 |
| Pictograms | GHS05,GHS07,GHS09 |
| Signal word | Warning |
| Hazard statements | Hazard statements: "H302, H315, H318, H335, H410 |
| Precautionary statements | Precautionary statements: "P261, P273, P280, P305+P351+P338, P310, P501 |
| NFPA 704 (fire diamond) | 2-0-2-W |
| Autoignition temperature | > 250°C |
| Lethal dose or concentration | LD50 oral rat 1823 mg/kg |
| LD50 (median dose) | 2,250 mg/kg (rat, oral) |
| NIOSH | SW4382500 |
| PEL (Permissible) | PEL: Not established |
| REL (Recommended) | 0.05 mg/m³ |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds | Dichlorodimethylhydantoin Bromochloromethane 1,3-Dibromo-5,5-dimethylhydantoin Sodium dichloroisocyanurate Trichloroisocyanuric acid |
| Section | Details | Manufacturer Commentary |
|---|---|---|
| Product Name & IUPAC Name |
Product Name: Bromochlorohydantoin IUPAC Name: 1-Bromo-3-chloro-5,5-dimethylhydantoin |
Production relies on the controlled halogenation of 5,5-dimethylhydantoin (DMH). Each batch requires tight feed control over bromine and chlorine ratios, as different market sectors—such as water treatment and sanitizing formulations—specify variant halogen profiles to tailor oxidizing characteristics and regulatory acceptance. Material nomenclature in procurement, customs clearance, and customer purchasing shifts according to IUPAC, common, and local trade designations, impacting documentation traceability and inventory accuracy. |
| Chemical Formula | C5H6BrClN2O2 | The molecular formula directly reflects the halogen source balance established during synthesis. For production lines, any deviation in elemental ratios signals upstream raw materials inconsistencies, process drift, or incomplete reaction—a situation monitored by periodic batch analytics. Different country and regional markets may reference variations in stoichiometry to address specific regulatory labeling or hazard communication schemes. |
| Synonyms & Trade Names |
Synonyms: BCDMH, 1-Bromo-3-chloro-5,5-dimethylhydantoin Trade Names: application- and region-specific; commonly indexed under pool, spa, and biocidal disinfectant formulations. |
The terminology shifts with end-use: water purification clients reference BCDMH, while institutional hygiene buyers focus on branded trade names derivative of product claims or formula blends. The precise name used in logistics and compliance records must match the sales contract, purchase order, and shipping documents; re-labelling disputes commonly arise from inconsistent synonym referencing between exporter and importer. |
| HS Code & Customs Classification |
Typical HS Code: 2933.69 Customs sub-classification and additional code digits may apply based on destination region regulations and declared end-use. |
Customs classification under HS Code 2933.69 tracks with derivatives of hydantoin. Additional harmonized tariff digits are imposed depending on the regional chemical control regime—some ports require extra declaration if the consignment targets biocide formulation manufacturers. Classification mistakes delay clearance, escalate costs, and risk bottle-neck at bonded warehouses. Every export lot undergoes harmonization database verification and batch documentation matching for expedited customs processing. Customs brokers often consult with manufacturing technical teams to clarify product basis compared to similar halogenated imidazolidinones, especially if mixed consignments include closely related compounds. |
In industrial batches, BCDMH consistently forms off-white to pale tan crystalline tablets, granules, or powder, depending on the drying and granulation protocols adopted during post-reaction handling. The characteristic odor resembles halogenated nitrogen compounds. Melting points reported in the literature occur within a defined range, typically monitored as a key indicator of purity and polymorphic consistency, as process adjustments or raw material drift may shift this profile.
Density varies by granule compactness and formulation, directly impacting blending, dispensing, and dissolution rates in downstream use or customer formulation. Boiling and flash points are not meaningful for BCDMH, as decomposition initiates at elevated heat, generating corrosive gases well before true boiling occurs. Dustiness affects worker safety and requires control during packaging and sampling.
As a halogenated hydantoin, BCDMH demonstrates solid phase stability under controlled humidity and temperature, but in field use or exposure to moisture, it hydrolyzes, liberating active bromine and chlorine. Oxidizing potential remains the centerpiece of its functional profile, supporting its role in biocidal formulations. Production batches must avoid ammonia, reducing agents, and strong bases during storage and transfer, as side reactions can trigger decomposition and safety hazards. Different applications may benefit from tailored stabilizer systems or co-formulant blends.
Solubility depends on water temperature, granule size, and pH. Fine powders dissolve quicker but are dustier and more reactive upon handling. Industrial solution make-down protocols adjust agitation, temperature, and dosing to suit batch size and intended use: pools, process water treatment, or paper manufacturing. Incompatibility with metal containers and some organic solvents means vessel selection and equipment cleaning routines are evaluated at customer or regulatory request.
Parameters such as BCDMH content, moisture, active halogen, and particle size are set per customer application and regional standards. Pool grade, industrial water treatment grade, and fine chemical grade differ in permitted impurity profile, active bromine/chlorine ratio, and physical form. Specification tables only represent batch release criteria, as actual process output is monitored to tighter internal limits. Exact figures are traced to lot analysis but not disclosed beyond controlled documentation.
The major impurities stem from incomplete halogenation, residual 5,5-dimethylhydantoin, and trace organic acids. Each production campaign generates characteristic byproduct signatures, monitored via chromatographic and titrimetric techniques. Impurity cut-offs are set lower for pharmaceutical-intermediate grades versus bulk chemical supplies. Removal of unreacted starting material, trihalomethanes, and heavy metals is prioritized during purification, with varying limit thresholds reflecting region-specific regulatory guidance.
Lot release utilizes titration for available halogen, loss on drying for moisture, and HPLC or GC-MS for organic and inorganic impurities. Standards referenced depend on customer agreements—ASTM or ISO methods for water treatment, local GB or EN for pool-grade, or in-house validated protocols for bespoke applications or where international standards lack granularity for detailed impurity classification. Comparative stability testing informs shelf life and packaging guidance.
Major raw materials include 5,5-dimethylhydantoin, bromine, and chlorine sources. Sourcing prioritizes purity to minimize feedstock-derived heavy metal or organic impurities, with supplier audits focusing on lot consistency. Solvent and catalyst residues from upstream bromine and chlorine generation sometimes trigger supply chain changeovers every year or two, especially for higher purity requirements. Logistics teams balance price, lead time, and consignment storage constraints.
The synthesis proceeds via controlled halogenation of 5,5-dimethylhydantoin with bromine and chlorine donors, adopting either sequential or simultaneous addition based on plant design. Reaction kinetics, mixing efficiency, and temperature control are fine-tuned to maximize yield while suppressing over-bromination and side-chain chlorination. Sulfate or phosphate buffers sometimes moderate pH to curb dichloro- or dibromo-byproduct formation.
Pilot and commercial scale lines monitor reactant addition rates, slurry agitation, jacket temperature, and byproduct gas venting. Purification steps rely on recrystallization in water or controlled solvent systems, aided by filtration or centrifugation. Off-gassing and wild halogenation risks demand robust ventilation, hooding, and vent scrubbers. Drying temperature and residence time impact final moisture—a critical determinant of stability and shelf life. Post-processing sieving or granulation grade the bulk product by intended market segment, with inline particle analysis and rotary valve feeding controlling lot-to-lot variability.
Quality labs collect in-process and final batch samples for analytics. Out-of-spec results commonly trace back to batch-to-batch raw material variance or deviations in addition rate. Statistical process control tracks active halogen variance, moisture, and contamination trends. Release batches must conform to agreed internal or external specs, verified via lot COA and archived retentions per regulatory traceability.
BCDMH’s main reactivity involves staged release of active bromine and chlorine ions upon hydrolysis. This underpins its use in disinfection, surface sanitation, and bleaching. Chemical modification potential explores N-alkylation, further halogen substitution, or hydantoin ring opening. Application-specific requests may involve custom blends with other oxidants or slow-release formulations.
Industrial applications see BCDMH reacting in neutral to slightly alkaline aqueous environments. Temperature impacts halogen release rates: higher temperatures accelerate decomposition, posing handling and dosing challenges at point of use. No external catalysts are required for the core hydrolytic activity, while proprietary field formulations may incorporate stabilizers or emergent co-catalysts for performance tuning.
By adjusting halogenation extent and pursuing N-halo derivatives, downstream manufacturing achieves a range of brominated or chlorinated hydantoin products. Blending with other sanitizer actives or chelating agents supports expanded uses from potable water treatment to specialized cleaning solutions. Innovation often stems from customer-driven collaboration for unique impurity profiles or dissolution properties.
Ambient storage in dry, well-ventilated warehouses preserves active halogen content and tablets’ mechanical integrity. Heat, sunlight, and high humidity accelerate decomposition and caking, while certain packaging resins fail under sustained halogen exposure. For bulk and repacked formats, lot-specific recommendations guide temperature and light exposure cut-offs. Controlled-atmosphere warehousing may be specified for premium grades, safety stock, or export consignments.
BCDMH demonstrates compatibility with high-density polyethylene and select fluoropolymer linings, resistant to halogen-induced weakening. Mild steel and low-grade plastics risk failure and require segregation. Manufacturer trials often anticipate customer handling—transport drum materials, liner thickness, and palletization protocols evolve in sync with regulatory demands and customer feedback on real-world storage performance.
Typical shelf life depends on packaging, grade, and storage. Clear signs of degradation include odor change, color darkening, or tablet friability. Every batch incorporates a defined maximum holding period, subject to periodic reevaluation depending on downstream re-certification or regulatory change.
Bromochlorohydantoin falls within the oxidizer and corrosive range of GHS hazard groups, depending on purity and blend. Pictogram use follows local transport regulations as updated per lot testing and SDS harmonization updates. The hazard level increases with increased dust, fine particle fraction, or elevated moisture leading to off-gassing.
Inhalation and skin exposure can cause irritation and respiratory distress. Eye contact risks severe injury. Combining BCDMH with organic materials, acids, or ammonia triggers hazardous gas generation, which guides our work area zoning, PPE choice, and spill response plans. Packaging carries region-tailored risk statements, updated annually with regulatory bulletins and injury report assessments.
BCDMH’s chronic and acute toxicity reflects its halogenating action. Typical manufacturer assessments reference industry studies and local authority guidance instead of specific numeric LD50 values. Occupational medicine reviews recommend minimizing dust and aerosol generation, with vigilance around pre-existing respiratory issues.
No universally applicable OEL has been specified. In-house procedures default to industry best practices: use of ventilation, automated handling, half-face or full-face respirators for open-pour lines, and skin protection. Safety teams regularly review incident logs, updating protocols to reflect evolving employee exposure experience.
Current investment in expanded synthesis lines has stabilized the throughput for Bromochlorohydantoin technical and granular grades. Tier-one manufacturers have invested in scaling reaction vessels and solvent recovery units to match the cyclic nature of demand. Annual output reflects feedstock supply and process line scheduling. Actual availability hinges on upstream halogen (bromine and chlorine) deliveries and cycle times, which are adjusted based on both seasonal pool-season spikes and regulatory allocations of controlled substances.
Order lead times typically fluctuate with raw material procurement and current run schedules. Internal batch hold and release protocols influence lead time, and lot reservation agreements for strategic buyers shorten requalification cycles. Minimum order quantity (MOQ) tracks with production campaign size. Bulk buyers in water treatment and disinfection applications often align with our batch sizes, whereas specialty requests in custom packaging require advance notice due to separate filling and QA/QC setup.
Packaging formats depend on customer handling systems and transport regulations. Standard offerings include fiber drums with liner, high-density polyethylene drums, and custom IBCs for bulk tank charging. Packaging is validated against BCDMH’s corrosivity and volatility; climate-controlled storage maintains product stability. Options for tamper-evident seals and UN-rated containers are available for hazardous goods compliance.
Shipping routes utilize land and maritime carriers authorized to move hazardous oxidizing materials. Carrier selection is based on destination, regulatory route restrictions, and transit time sensitivity. Payment terms reflect customer standing and risk protocols—standard terms apply after completion of anti-diversion checks and credit review. Documentary requirements shift per jurisdiction: exporters comply with local and importing country chemical controls.
BCDMH raw material calculations follow the volatility of bromine and chlorine markets. Feedstock grade, source of halogen, and stepwise purification yield significant swings in cost of goods sold. Raw material input pricing is not uniform; domestic and imported bromine present marked price differences driven by extraction costs and applicable tariffs.
Raw material price jumps originate from halogen production quotas, environmental curtailments, and energy-intensive extraction. Unexpected plant shutdowns in upstream bromine or caustic soda directly impact manufacturing expense. Bulk commodity price shifts, energy pricing, and regulatory changes apply measurable influence to periodic production costs.
BCDMH grades—technical, pharmaceutical, or customized granular—demand discrete purification and quality criteria. Higher purity requests raise both processing and analytical validation expenses. Packaging certification (e.g., FDA, EPA, or REACH-listed containers) also introduces measurable cost tiers across export markets.
End-use grade demands set price band differences. Water treatment and municipal disinfection rely on technical or standard purity, while high-purity or food-contact applications require additional in-process controls, driving up per-unit price. Packaging certification for special markets (such as US EPA or European chemicals compliance) requires material traceability and documentation, justifying higher pricing versus commodity grades.
BCDMH demand tracks closely with seasonal swimming pool, spa, and industrial recirculation markets. China remains a leading producer, exporting to regulated and emerging markets. Risk factors include trade policy, local demand shifts, and halogen extraction constraints. Global supply remains balanced so long as upstream bromine and chlorine availability remains normal.
| Region | Supply Observations | Demand Drivers |
|---|---|---|
| US | Stable local synthesis and imports. Regulatory-driven price floors. | Municipal disinfection, pool seasonality, EPA standards. |
| EU | Import-reliant, REACH certification adds cost. Packaging differentiation required. | Strict product stewardship, water reuse, and hygiene regulations. |
| JP | Limited internal production. High-purity imports prioritized. | Pharmaceutical and semiconductor disinfection protocols. |
| IN | Increasing domestic production, fluctuating feedstock costs. | Growing municipal/institutional demand, price-sensitive markets. |
| CN | Dominant global supplier, benefits from domestic bromine but susceptible to export control. | Strong internal demand, export allocations managed tightly. |
Price in 2026 will depend on bromine supply normalization, downstream regulatory changes in major economies, and growth in municipal and recreational water disinfection demand. Escalating environmental controls in China and India could push production costs upward. Regulatory-driven upgrades in packaging and documentation requirements in US and EU will likely widen price tiers by grade. Multiple supply chain disruptions—whether by geopolitical action, shipping constraints, or feedstock price shocks—remain the key risk factors likely to cause sharp but temporary price spikes.
Analysis draws from internal production cost tracking, aggregated global trade data, public tender reports, and export terminals monitoring in bromine-producing regions. Reference pricing does not reflect end-user bid results; it incorporates regulatory regimes, seasonal supply, plant maintenance cycles, and market-specific feedback from direct customers.
Sustained enforcement of stricter halogen handling regulations by environmental ministries in bromine-producing countries has tightened quarterly availability for industrial users. International chemical safety regimes have prompted accelerated phaseout of legacy packaging types and raised the documentation burden for all exporters. The merger and capacity consolidation among major bromine suppliers have resulted in more predictable, but sometimes less flexible, BCDMH supply streams.
2023–2025 regulatory cycles have produced stricter limits on hazardous substance release and new requirements for traceability in packaging, especially in the EU. Importers now require full traceability from raw feedstock to packaged goods. Packaging now follows updated standards for exposure minimization, aided by serialized tracking codes.
Manufacturers have adopted in-process video monitoring and batch digitalization to track critical control points and minimize off-spec generation. Enhanced bromine sourcing contracts and multi-site diversification mitigate risk. Process improvements target reduction of unwanted by-product halogenated impurities to comply with emerging regional standards. Internal QA/QC teams have formalized batch release protocols to include additional purity and heavy metal checks when destined for high-scrutiny export markets.
Bromochlorohydantoin serves several major sectors. Water treatment operations favor its strong biocidal performance in swimming pools, industrial cooling systems, and process water sterilization. The product’s suitability for sanitizing recirculating water comes from its ability to deliver both bromine and chlorine effectively. Specialized formulations support food processing plant sanitation, where strict control over residuals and byproducts is needed. In aquaculture, both municipal and agricultural, specific concern centers on dose control and avoidance of undesirable halogenated disinfection byproducts. Paper mills and beverage facilities rely on consistent active ingredient levels and minimal insoluble content to protect pipelines and prevent fouling. Demand from the oil and gas sector includes both injection well biocide treatments and completion fluids.
| Application Area | Preferred Grade | Key Considerations |
|---|---|---|
| Swimming Pools & Spas | General/Standard Grade | Active content, reasonable control over insolubles |
| Industrial Water Treatment | Technical/High Purity | Batch consistency, control on secondary halogen release |
| Food Processing | Special Purity, Low Residuals | Screening for formaldehyde, heavy metals, organic byproducts |
| Aquaculture | Low Residuals, Controlled Release | Careful management of bromine and chlorine residuals, granule size |
| Oil & Gas Fields | High Activity, Controlled Moisture | Bulk stability, minimum fines, adaptability to brine conditions |
In our production, active ingredient release rate is managed by both granule size and matrix composition. For pool and spa use, active bromine content levels are balanced against dissolution speed. In industrial cooling systems, demand leans toward grades with minimum inorganic insolubles and controlled mesh sizes for automated dosing systems. Applications in food and beverage require not only tight control of microbiological purity but also regular screening for unwanted secondary amines and aldehyde byproducts. Oilfield applications challenge the product with higher temperatures and a broad range of solution chemistries; here, moisture content and dust/fines level set key processing criteria. Each of these requirements is tied to the manufacturing batch process, in-line controls, and end-of-line release testing.
Begin by determining if the application is open (e.g., swimming pools), closed-loop industrial circuit, food-contact surface, agricultural/aquatic, or downhole treatment. Each sector imposes different demands on product form, dissolution, and residual content.
Check for regional compliance needs. Regulations on halogen biocides differ for pools, food-contact sanitization, aquaculture, and industrial discharge. Some regions require formal certification or proof of specific impurity limits. Our technical staff aligns grade assignment with declared use and regional expectation.
Customary industrial practice sets purity control levels specific to downstream handling and base raw material input. For direct water contact or food surfaces, batches undergo extra purification steps and batch-wise impurity profiling, subject to in-process monitoring. Routinely, we adjust synthesis and purification parameters according to declared downstream needs, which also governs post-synthesis handling and packaging choices.
Process selection (batch vs. continuous) reflects target supply volume and cost priorities. High-volume industrial consumers often select technical grades, meeting requirements for dosing and biocidal effect while managing costs. Lower-throughput, critical-use sectors, such as beverage processing or aquaculture, favor premium grades with additional purification and tighter analytical batch signing.
Before full-scale order, customers request preselected grade samples. Our technical service matches candidate grades to the application profile, then supports customer-site validation through data sharing and documentation. Our quality department coordinates release standards and final batch performance with the customer’s downstream process-critical criteria before routine supply begins.
Our production of Bromochlorohydantoin operates under a formally established quality management framework based on recognized international standards. Audit readiness remains an ongoing exercise in our team, driven by a commitment to transparent traceability, root-cause analysis of deviations, and documentation discipline across shift changes and batch records. The approach covers site-wide system audits, calibration management, and proficiency testing in analytical laboratories with external validation as required by contract partners and regulatory bodies. The plant’s quality function monitors process-critical points from raw material intake to packaging integrity, allowing us to deliver predictable output with traceable batch genealogy and minimal cross-contamination risk.
Certifications pertaining to BCDMH depend heavily on market region, customer segment, and application. For water treatment and sanitization uses, product conformance typically references local or national regulatory approvals, each with individual impurity profiles, moisture content guidelines, and compositional boundaries. We support customers with certificates of analysis for every delivery, including actual measured parameters as mandated by the destination jurisdiction or application segment (for example, stabilization in tablet or granular formulations). Custom testing regimens are available by pre-arrangement, covering microbiological purity, bromine/chlorine ratio, and trace material limits as agreed with the end user.
Every BCDMH batch is accompanied by technical documentation and analytical reports aligned to contractual specifications. These documents detail methods used, detection limits and laboratory validation intervals, as well as data on lot release and in-process control checkpoints. For regulatory submissions or customer audits, dossier support includes site master files, change control logs, and historical deviation reports. Certificates of origin and transportation documentation—such as Dangerous Goods Declarations—are prepared according to prevailing chemical logistics rules in the export destination. Gap analyses for documentation completeness can be run upon request for specific compliance contexts.
Manufacturing of BCDMH follows a process route optimized for yield and repeatability, with raw material sourcing contracts focusing on reliability and long-term continuity. Forecasted offtake volumes and client call-offs drive production scheduling, supported by multi-line redundancy and modular batch capacity. We engage in forward planning with enterprise buyers to identify supply cycle bottlenecks ahead of high-demand seasons or regulatory constraints. For new projects, flexibility is built into framework agreements, supporting volume adjustments and phase-in/phase-out schedules matched to end use or regional rollout.
Core capacity is based on main reactor throughput, drying and sizing assets, and packaging lines capable of handling multiple form factors—granules, tablets, or powders. Consistency is achieved through tight process window control, routine maintenance windows, and contingency scenarios for supply disruptions. Inventory buffers exist both at plant and in regional third-party logistics hubs, configured according to historical drawdown statistics and geographical lead times. Ongoing investment in debottlenecking projects aims to keep cycle time and order lead times predictable for repeat contracts, with surge capacity triggered during contractually confirmed short-term spikes.
Sample applications require input on intended application, expected regulatory destination, and required analytical specifics. The laboratory prepares representative batches for the requested grade scenario and provides these with batch-specific CoA and supporting safety documentation. For novel formulations or cross-application testing, technical service consultation is available to evaluate interaction risks, formulation compatibility, or storage sensitivities. Typical sample lead time varies with product form and region of dispatch, with strict controls against mixing lots or cross-batch contamination during preparation.
Flexible cooperation models cover a range of business needs, from long-horizon blanket contracts with call-off rights to spot buys for seasonal or validation projects. For strategic partners with joint development requirements, supply frameworks may incorporate shared risk for input material volatility or equipment downtime. OEM and private-label options exist, supported by co-brand documentation and unique batch traceability protocols. Escalation procedures provide for alternate supply arrangements in the event of upstream raw material disruptions or logistics constraints. Contractual flexibility extends to adaptation of batch sizes, adjustment of delivery frequency, and periodic product customization reviews per evolving application requirements.
R&D groups at manufacturing sites concentrate on optimizing yields, reducing solvent loss, and controlling polymorph consistency for BCDMH. Focus continues on minimizing byproduct formation, specifically unreacted halogenated intermediates, by real-time monitoring during halogenation. Teams dedicate considerable effort to refining crystal morphology for fast dissolution in formulated tablets and powders, which is crucial for commercial pool and spa sanitizers. Various processing teams work on direct tableting blends that balance dissolution rate against dust generation—a key customer concern in bulk disinfection and water treatment sectors.
End-use applications for BCDMH change according to disinfection trends and regulatory updates. Shift in the regulatory landscape, such as limits on free bromine and byproduct residues in treated water, drives development of tailored grades. Larger end users raise questions about suitability for advanced oxidation processes and reuse in recirculated cooling water, which influences pilot testing on formulation compatibility and residual control. Some technical groups collaborate with institutional hygiene and process water sectors to adapt BCDMH forms for misting and fogging applications, where product purity and granule stability during prolonged storage are focus areas.
A persistent technical challenge lies in achieving consistent halogen content across batches, as upstream material quality and process climate (especially humidity and temperature swings) directly affect halogenation extent and product stability. Plants equipped with automated, closed-system handling reduce variability; real-time Raman or FTIR checks provide actionable data for in-process adjustment. Engineering teams continue to implement scrubbing and recycling systems for effluent gases to reduce environmental footprint at source. Recent efforts on stabilizer incorporation during granulation show promise in extending shelf life and reducing caking in high-humidity conditions, a persistent issue for bulk supply in tropical regions.
Demand projections indicate steady growth in BCDMH consumption in municipal water treatment and recreational water sectors, especially as emerging regions invest in safer water infrastructure. Regulatory push for alternatives to gaseous chlorine maintains market relevance for solid halogen donors. New applications in cooling tower water microbiological management drive demand for custom blends and packaging innovations. Growth rates and pricing may vary depending on regulatory reviews and raw material volatility; technical partnerships with large end users play a significant role in captive supply agreements.
Production lines are moving toward closed automated systems to cut exposure and enhance batch reproducibility, supported by digital batch records and automated in-line halogen content testers. Crystallization tanks with variable agitation modes offer improved control over physical form, critical for downstream compaction and dust characteristics. Cleaner reaction routes under investigation aim to lower levels of residual organic contaminants, aligning with end-user VOC and DBP compliance targets. Tablet and granular product forms frequently benefit from feedback-driven optimization, emphasizing reduced friability without compromising dissolution performance in finished applications.
Sourcing strategy now prioritizes raw materials with documented traceability and lower lifecycle environmental burden. Waste minimization at the halogenation stage, by means of secondary recovery of byproduct halides, remains a key target. Formulators work to reduce persistent impurities that increase aquatic toxicity. Facilities implementing on-site water reuse and active solvent recovery contribute to sustainability reporting, especially for regions under strict discharge frameworks. Teams review packaging material selection to encourage higher post-consumer recyclability, responding to client sustainability audits.
Technical support engineers engage directly with customer QA and technical staff to review application scenarios, especially in novel biocidal settings or process water with variable pH. Consultation addresses grade selection, analysis methodology matching (e.g., ensuring halogen titration aligns with expected product form), and troubleshooting of physical separation or caking in high-volume dosing systems.
Support teams collaborate with end users to adjust blending or dosing to match site-specific water chemistry and flow rates, based on field performance data. Application specialists often assist with bench-scale and pilot trials, measuring residuals, release profiles, and physical changes under real-use conditions. When downstream issues such as halogen off-gassing or scale deposition arise, technical support proposes changes in product grade, feed rate, or ancillary equipment compatibility, prioritizing production continuity.
Commitment focuses on post-shipment technical tracking—product teams trace batch performance and rapidly respond to field feedback, offering analytical re-verification where required. Field visits by technical managers to large-volume sites address practical concerns (such as bulk storage, tablet integrity in high humidity, or dispenser compatibility) and close the feedback loop for ongoing product and process improvement. Dedicated fault review procedures, with cross-department input from QC, production, and R&D, ensure customer issues drive continuous knowledge transfer to both current batches and future technical development.
Our production lines deliver Bromochlorohydantoin under tightly controlled conditions to meet the needs of demanding industrial applications. The entire synthesis and tablet-pressing process takes place inside our own facility, with batch records documented along every step. By controlling each stage, we remain responsive to shifts in particle size preferences, tailored concentrations, and evolving supply schedules in water treatment, sanitation, and downstream processing.
Bromochlorohydantoin provides effective control over bacteria, algae, and other unwanted organisms in large-scale cooling towers, power plants, and aquaculture installations. Municipal water systems and food-processing environments also use BCDMH for surface and equipment disinfection where consistent performance under fluctuating pH matters. Our technical teams regularly troubleshoot application challenges associated with fluctuating pond temperatures and chemical interactions, ensuring that the product fits the operating realities of each facility.
Monitoring each batch at the raw material input, reaction, granulation, and tableting phases helps maintain a tight specification for halogen content, available chlorine, and release rate. For every production run, in-house laboratories conduct assays to confirm composition as well as checks for residual moisture and tablet hardness stability. These records are available for audit. Buyers do not face unknowns regarding what arrives with each order: test results are traceable back to our production lines.
Demand for packaging varies across markets, so we developed a range of options including moisture-proof drums, sealed fiber cartons, and custom containers for automated feeders. Shipment scheduling reflects seasonal surges in cooling season and the tight windows experienced by commercial water treatment operators. Automated warehousing helps manage high-volume orders and mixed pallet requests, keeping lead times predictable even during peak months.
Industrial-scale use of BCDMH introduces challenges related to dilution, dosing automation, and feed system compatibility. Our technical managers routinely visit sites and guide conversion projects, from legacy chlorine systems to halogen tablets. We work directly with plant maintenance managers and engineers to review application trends and optimize dosing programs, building long-term operational data on performance under actual working conditions.
Direct manufacturing control allows predictable product quality, cost management, and uninterrupted supply. Distributors supporting regional markets receive volume flexibility without speculation or dependence on secondary supply channels. Procurement teams gain from transparent QC protocols and verifiable specification sheets without ambiguity regarding source or compliance. Product support remains available for both troubleshooting and adapting to regulatory changes on active substance usage in industrial sanitation and municipal water applications.
Customers regularly ask about the bromine and chlorine content in Bromochlorohydantoin (often called BCDMH) and its relationship to microbial kill rates in water treatment. Our team handles every stage of BCDMH production at our facility, so we have a ground-level perspective on why these specific percentages matter for end-use performance.
The molecule of BCDMH features both bromine and chlorine atoms firmly bonded to a hydantoin ring. In our standard batches, the bromine content typically sits within the range of 31-33%. Chlorine content averages around 36-38%. These values result from tight process controls and ongoing quality checks at every step of the production cycle.
We maintain these targets because the dual-halogen formulation triggers a disinfection mechanism that leverages the strengths of both elements. Bromine alone performs well in higher pH water, offering more stability and persistent action compared to stand-alone chlorinated agents. Chlorine contributes a rapid initial oxidizing response, quickly eliminating a broad spectrum of bacteria and algae even in heavily contaminated or fast-moving water systems.
Our laboratory studies and ongoing field testing constantly reaffirm that the bromine and chlorine must be present in the correct proportions to ensure the sought-after broad spectrum activity. Too little bromine and the persistent kill strength drops off, especially as water pH rises. Too little chlorine lengthens the time it takes to get an initial microbial knockout, particularly in heavily loaded systems.
We have seen water treatment operators stray from recommended ranges in an effort to tweak costs or formulations, only to run into issues. Out-of-balance BCDMH tends to leave residual organics, result in bacterial rebound, or cause more frequent need for system draining and cleaning. Our technical consultations with these operators almost always point them back to the necessity of consistent bromine and chlorine content as set forth by chemical engineering best practices.
Every BCDMH lot we send out undergoes duplicate laboratory analysis for halogen content. Instruments such as elemental analyzers and titration systems confirm that bromine and chlorine remain in spec. Our production lines have built-in verification points; deviations trigger batch review and, if required, full reprocessing. This is our key to supplying stable, high-performance product that consistently meets disinfection demands across pool, spa, cooling tower, and industrial applications.
Pools, spas, and closed-loop cooling systems present different microbial and chemical load profiles. A robust BCDMH tablet, powder, or granular agent needs to keep pace with both aggressive organic input and the call for operator convenience. Our in-house research team tracks regulatory trends and frequent customer feedback to fine-tune ratios and packaging for each application. The right halogen balance means the product works at lower dosages, introduces less byproduct, and supports easier compliance monitoring.
Operators with specialized water challenges can request additional product data, application advice, or on-site testing support directly from our technical group. All recommendations and troubleshooting draw on real batch performance data and field experiences from customers using our product. Keeping BCDMH production and application under one roof lets us troubleshoot quickly and provide solutions grounded in actual manufacturing and field realities.
Bromochlorohydantoin, often called BCDMH, moves out of our factory packed to meet both logistical needs and essential safety standards. Many clients want to get a handle on what quantity marks the starting line for a direct purchase and what packaging options line up on our loading docks. A clear answer here helps everyone plan inventory, freight, and application needs from day one.
For BCDMH, our minimum order quantity starts at 500 kilograms. This threshold matches a typical production batch, which keeps the process economical while still offering a manageable volume for end-users. Above this size, we have no restrictive upper limits on large-volume orders—our production lines are designed for continuous output, blending consistency and product traceability in each lot. Our direct customers include water treatment firms, pool chemical blenders, and industrial cleaning agents manufacturers, all of whom rely on consistent supply lot after lot, not sporadic volumes from piecemeal sources.
BCDMH demands robust containment, both for purity and for regulatory transport. We package the product in high-density polyethylene drums with tight-seal lids, always aiming to lower spillage risks while keeping material flow practical for downstream process steps. The primary drum size holds 25 kilograms net, which allows for both manageable drum handling and efficient container loads. Some customers opt for our 50 kilogram fiber drums, which supply larger operations with less frequent drum changes at mixing stations.
For clients moving much larger volumes through automated dosing or blending lines, we also fill 500 kilogram IBCs (Intermediate Bulk Containers). These bulk containers reduce packaging waste and packing time for customers running continuous operations, as they can connect dosing directly to the IBC instead of transferring from small drums. Every drum and IBC carries a batch label with identification traceability, so if your QC team needs a product sample from earlier shipments, we can track every drum right back to its production lot without delay or ambiguity.
Setting fair and transparent MOQs makes planning easier. Our manufacturing schedules need steady ordering patterns to keep costs down for both sides. Shipping smaller amounts in custom-sized containers would slow down fulfillment and raise overall risk—BCDMH is a powerful and regulated biocide, requiring careful documentation and compliant handling from factory gate all the way to your warehouse.
Our technical and logistics teams regularly review customer feedback about packaging usability. Some operations want easy drum-lifting and pouring; others prize bulk IBCs for the lowest labor input. We factor in what clients share about their workflows, just as much as what regulators demand. Packaging also shapes the shelf-life: tightly sealed drums protect from contamination and moisture, two major enemies of product stability in chemical distribution and storage.
We welcome bulk contract orders for clients with ongoing usage patterns. For add-on orders or one-off project needs, we offer split-shipment solutions where feasible, always prioritizing site safety and product stewardship. Our team can supply detailed batch COAs and technical support direct from the production lab, not filtered through trading intermediaries.
From starting production batches through to the last IBC on a full container load, setting clear minimums and practical packaging sizes keeps your teams running on schedule, every order. With BCDMH, direct-from-manufacturer sourcing means traceability, reliability, and readiness right from the shop floor.
Manufacturing Bromochlorohydantoin (BCDMH) gives us a firsthand view of its chemical properties, risks, and responsibilities. This product falls under the classification of oxidizing materials and strong irritants, requiring clear attention to storage and logistics. Over the years, as we’ve expanded our production capabilities, we have had to design transportation and storage protocols that meet strict legal standards and practical handling needs.
BCDMH draws attention in regulatory frameworks because of its potent oxidizing action and potential to react with organic matter or moisture. During transport and storage, this material must remain dry and isolated from other chemicals, especially flammables or acids. Our regular process audits show that cross-contamination or accidental mixing with incompatible materials presents the greatest risk. We work with our logistics and warehouse teams to reinforce clear zoning and separation.
Legal requirements, including those found in ADR/RID, IMDG, and domestic transport codes, set the bar for labeling, container standards, and declaration protocols. We use UN-approved drums and pails, sealed for moisture protection and reinforced for impact resistance. Double-walled HDPE containers have proven the most reliable for domestic and international loads. Every shipment moves under official hazardous goods documentation, with clear identification on packages and transport vehicles. Our experience has always shown that meticulous labeling and using the correct hazard placards cut down on customs delays and reduce misunderstandings at transit hubs.
On-site warehouses for BCDMH maintain low humidity and stable ambient temperature. Storage areas feature grounded shelving to limit static risk, and we continuously monitor for spilled residues or container damage. Our operations team reviews storage maps every quarter, repositioning product pallets away from heat sources or windows. The building infrastructure incorporates secondary containment and emergency wash-down systems, giving us rapid response capability if spills occur.
All staff involved in handling BCDMH undertake chemical safety training before starting their shift. We reinforce basic protocols—never use metal scoops, never break open containers outside the approved filling room, and always work with gloves and respiratory protection. Our direct incident log focuses on practical reminders: check drum seals, inspect packaging integrity, record each movement in the materials management system.
Regulations only cover so much. We supplement legal minimums with practical steps born from daily experience. Periodic internal drills test our emergency procedures; recorded incident reviews inform training updates. Our technical team provides clear storage charts and hands-on guidance to industrial users, outlining which warehouse chemicals pose compatibility risks. If a customer needs to repackage material, we provide recommendations on the best available packaging and handling equipment.
BCDMH is a valuable and powerful chemical. Our commitment runs deeper than compliance—years of direct manufacturing and logistics work show that diligent record-keeping, quality packaging, and ongoing staff education create the safest transportation and storage environment. Any customer receiving our product gets the benefit of learned best practices integrated into every unit we ship.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327